Induction of Apoptosis by HDAC Inhibitor Trichostatin A through Activation of Caspases and NF-κB in Human Prostate Epithelial Cells. |
Park, Cheol
(Department of Biological Sciences, Pusan National University)
Jin, Cheng-Yun (Department of Biochemistry, Dongeui University College of Oriental Medicine and Department of Biomaterial Control (BK21 program), Dongeui University Graduate School) Choi, Byung-Tae (Department of Anatomy, Graduate School of Oriental Medicine, Pusan National University) Lee, Won-Ho (Department of Biological Sciences, Pusan National University) Choi, Yung-Hyun (Department of Biochemistry, Dongeui University College of Oriental Medicine and Department of Biomaterial Control (BK21 program), Dongeui University Graduate School) |
1 | Peltonen, K., T. M. Kiviharju, P. M. Jarvinen, R. Ra and M. Laiho. 2005. Melanoma cell lines are susceptible to histone deacetylase inhibitor TSA provoked cell cycle arrest and apoptosis. Pigment Cell Res. 18, 196-202. DOI ScienceOn |
2 | Komata, T., T. Kanzawa, T. Nashimoto, H. Aoki, S. Endo, T. Kon, H. Takahashi, S. Kondo and R. Tanaka. 2005. Histone deacetylase inhibitors, N-butyric acid and trichostatin A, induce caspase-8- but not caspase-9-dependent apoptosis in human malignant glioma cells. Int. J. Oncol. 26, 1345-1352. |
3 | Kim, H. R., E. J. Kim, S. H. Yang, E. T. Jeong, C. Park, J. H. Lee, M. J. Youn, H. S. So and R. T. Park. 2006. Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway? Exp. Mol. Med. 38, 616-624. DOI ScienceOn |
4 | Kim, Y. K., E. K. Lee, J. K. Kang, J. A. Kim, J. S. You, J. H. Park, D. W. Seo, J. W. Hwang, S. N. Kim, H. Y. Lee, H. W. Lee and J. W. Han. 2006. Activation of NF-kappaB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: its implication for resistance to apoptosis. Cell Death Differ. 13, 2033-2041. DOI ScienceOn |
5 | Greenberg, V. L., J. M. Williams, J. P. Cogswell, M. Mendenhall and S. G. Zimmer. 2001. Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells. Thyroid 11, 315-325. DOI ScienceOn |
6 | Kaufmann, S. H., S. Desnoyers, Y. Ottaviano, N. E. Davidson and G. G. Poirier. 1993. Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 3976-3985. |
7 | Platta, C. S., D. Y. Greenblatt, M. Kunnimalaiyaan and H. Chen. 2007. The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. J. Surg. Res. 142, 219-226. DOI ScienceOn |
8 | Philchenkov, A., M. Zavelevich, T. J. Kroczak and M. Los. 2004. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp. Oncol. 26, 82-97. |
9 | Marks, P. A., V. M. Richon, T. Miller and W. K. Kelly. 2004. Histone deacetylase inhibitors. Adv. Cancer Res. 91, 137-168. DOI ScienceOn |
10 | Barisic, K., J. Petrik and L. Rumora. 2003. Biochemistry of apoptotic cell death. Acta. Pharm. 53, 151-164. |
11 | Baradari, V., A. Huether, M. Hopfner, D. Schuppan and H. Scherubl. 2006. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. Endocr. Relat. Cancer 13, 1237-1250. DOI ScienceOn |
12 | Antonsson, B. and J. C. Martinou. 2000. The Bcl-2 protein family. Exp. Cell Res. 256, 50-57. DOI ScienceOn |
13 | Pan, L. N., J. Lu and B. Q. Huang. 2007. HDAC Inhibitors: A potential new category of anti-tumor agents. Cell Mol. Immunol. 4, 337-343. |
14 | Fan, T. J., L. H. Han, R. S. Cong and J. Liang. 2005. Caspase family proteases and apoptosis. Acta. Biochim. Biophys. Sin. (Shanghai) 37, 719-727. DOI ScienceOn |
15 | Fulda, S. and K. M. Debatin. 2004. Apoptosis signaling in tumor therapy. Ann. N. Y. Acad. Sci. 1028, 150-156. DOI ScienceOn |
16 | Li, G. C., X. Zhang, T. J. Pan, Z. Chen and Z. Q. Ye. 2006. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest. Int. J. Urol. 13, 581-586. DOI ScienceOn |
17 | Kwon, O., K. A. Kim, S. O. Kim, R. Ha, W. K. Oh, M. S. Kim, H. S. Kim, G. D. Kim, J. W. Kim, M. Jung, C. H. Kim, J. S. Ahn and B. Y. Kim. 2006. NF-kappaB inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells. Carcinogenesis 27, 2258-2268. DOI ScienceOn |
18 | LaCasse, E. C., S. Baird, R. G. Korneluk and A. E. MacKenzie. 1998. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17, 3247-3259. DOI ScienceOn |
19 | Lee, C. H., Y. T. Jeon, S. H. Kim and Y. S. Song. 2007. NF-kappaB as a potential molecular target for cancer therapy. Biofactors 29, 19-35. DOI ScienceOn |
20 | Donadelli, M., C. Costanzo, L. Faggioli, M. T. Scupoli, P. S. Moore, C. Bassi, A. Scarpa and M. Palmieri. 2003. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Mol. Carcinog. 38, 59-69. DOI ScienceOn |
21 | Facchetti, F., S. Previdi, M. Ballarini, S. Minucci, P. Perego and C. A. La Porta. 2004. Modulation of pro- and anti- apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors. Apoptosis 9, 573-582. DOI ScienceOn |
22 | Rupinder, S. K., A. K. Gurpreet and S. Manjeet. 2007. Cell suicide and caspases. Vascul. Pharmacol. 46, 383-393. DOI ScienceOn |
23 | Yoshida, M., M. Kijima, M. Akita and T. Beppu. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265, 17174-17179. |
24 | Schulze-Osthoff, K., D. Ferrari, M. Los, S. Wesselborg and M. E. Peter. 1998. Apoptosis signaling by death receptors. Eur. J. Biochem. 254, 439-459. DOI ScienceOn |
25 | Sarkar, F. H. and Y. Li. 2008. NF-kappaB: a potential target for cancer chemoprevention and therapy. Front. Biosci. 13, 2950-2959. DOI |
26 | Wetzel, M., D. R. Premkumar, B. Arnold and I. F. Pollack. 2005. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis. J. Neurosurg. 103, S549-S556. |
27 | Wylie, A. H., J. F. Kerr and A. R. Currie. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251-306. DOI |
28 | Shetty, S., B. A. Graham, J. G. Brown, X. Hu, N. Vegh-Yarema, G. Harding, J. T. Paul and S. B. Gibson. 2005. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. Mol. Cell Biol. 25, 5404-5416. DOI ScienceOn |
29 | Vanhaecke, T., P. Papeleu, G. Elaut and V. Rogiers. 2004. Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. Curr. Med. Chem. 11, 1629-1643. DOI ScienceOn |
30 | Rundall, B. K., C. E. Denlinger and D. R. Jones. 2004.Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death. Surgery 136, 416-425. DOI ScienceOn |
31 | Salvesen, G. S. and C. S. Duckett. 2002. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell. Biol. 3, 401-410. DOI ScienceOn |
32 | Ramsamooj, P., M. Kuettel, A. Dritschilo and M. Jung. 1997. p53-Independent tumorigenic progression of human prostate cells. Radiat. Oncol. Investig. 5, 269-274. DOI ScienceOn |
33 | Savickiene, J., G. Treigyte, V. Borutinskaite, R. Navakauskiene and K. E. Magnusson. 2006. The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acid-induced differentiation. Ann. N. Y. Acad. Sci. 1091, 368-384. DOI ScienceOn |